Abstract-A reliable and accurate identification of the type of tumors is crucial to the proper treatment of cancers. In recent years, it has been shown that sparse representation (SR) by l 1 -norm minimization is robust to noise, outliers and even incomplete measurements, and SR has been successfully used for classification. This paper presents a new SR-based method for tumor classification using gene expression data. A set of metasamples are extracted from the training samples, and then an input testing sample is represented as the linear combination of these metasamples by l 1 -regularized least square method. Classification is achieved by using a discriminating function defined on the representation coefficients. Since l 1 -norm minimization leads to a sparse solution, the proposed method is called metasample-based SR classification (MSRC). Extensive experiments on publicly available gene expression data sets show that MSRC is efficient for tumor classification, achieving higher accuracy than many existing representative schemes.
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INTRODUCTION
A tumor is a neoplasm or a solid lesion formed by an abnormal growth of cells. A reliable and accurate identification of the type of tumors is crucial to the effective treatment of cancers. Tumor is different from cancer. A tumor can be benign, premalignant, or malignant, while only the malignant tumor can be called cancer. The management of cancer has been attracting tremendous attention because cancer is a potentially life-threatening disease caused by the unchecked proliferation of cells.
DNA microarray is a biotechnology that simultaneously monitors the expression of tens of thousands genes in cells [1] . One important and emerging application of microarray gene expression profiling is tumor classification [2] , [3] . Many classification methods originated from statistical learning theory have been adapted for molecular data classification or clustering [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [25] , [26] , [38] , [39] . Golub et al. [3] successfully classified acute myeloid leukemia from acute lymphocytic leukemia using gene expression data. Huang et al. [9] proposed to use independent component analysis (ICA) based penalized discriminant method for tumor classification. Brunet used nonnegative matrix factorization (NMF) to cluster tumor samples. A major methodological concern of such methods is the problem of overfitting, i.e., method become overoptimized to perform well on the training set, but does not generalize well to new data from the same class of cancer [11] .
Sparse representation (SR) is a new and powerful data processing method, which is inspired by the recent progress of l 1 -norm minimization-based methods such as basis pursuing [12] , compressive sensing for signal reconstruction [13] , [14] , [15] , and least absolute shrinkage and selection operator (LASSO) algorithm for feature selection [16] . By using the SR technique to represent the input testing face image as a sparse linear combination of the training samples, an SR-based classification (SRC) method was proposed in [18] for face recognition. Ideally, in SRC it is expected that a testing sample can be well represented by using only the training samples from the same class. In such case, the SR coefficient vector will have only a few significant coefficients. In order to find the SR coefficient vector, l 1 -regularized least square [17] is used. Unlike conventional supervised learning methods, where a training procedure is used to create a classification model for testing, the SRC does not contain separate training and testing stages so that the overfitting problem is much lessened. The SRC method has been successfully used in face recognition [18] and tumor classification [19] . In these methods, a testing sample is represented as the linear combination of the original training samples, and the representation error over each class is used as an indicator to classify the testing sample. However, the original training samples may be not as efficient as the eigenfaces [20] or metasamples [5] , which contain the intrinsic structural information of the data, to represent the input testing samples.
A metasample is a linear combination of the gene expression profiles of samples, which can capture the alternative structures inherent to the data. The samples are analyzed by summarizing their gene expression patterns in terms of expression patterns over the metasamples. In [5] , [21] , the metasample expression patterns discovered by NMF provide a robust clustering of samples. 1 In [22] , the authors proposed a similar method called Eigenarrays, which are extracted by using singular value decomposition (SVD) or principal component analysis (PCA) from the gene expression data. For the convenience of expression, we use the word metasample throughout the paper. The metasamples can be computed by using SVD, PCA, NMF, or other linear or nonlinear models such as ICA and nonlinear ICA [23] , [24] .
In this study, we propose to represent each testing sample as a linear combination of a set of metasamples extracted from all the training samples. Classification is achieved by using a discriminating function of the representation coefficients on the metasamples obtained by l 1 -regularized least square. Since l 1 -norm minimization could lead to sparse solution, our approach is then named as metasamplebased sparse representation classification (MSRC).
The rest of the paper is organized as follows: Section 2 describes the methods proposed in this study. The SR of tumor samples and the metasample model of gene expression data are first presented, and the algorithm of MSRC is consequently given. Section 3 presents the numerical experiments. Section 4 concludes the paper and outlines directions of future work.
The abbreviations used in this paper are summarized in Table 1 .
METHODS
Sparse Representation of Testing Tumor Samples
The basic problem of supervised tumor classification is how to use the labeled training samples from the k object classes to correctly identify the class to which a new testing sample belongs. Consider a training gene expression data set represented by an m Â n matrix A with m genes and n samples. Since the microarray data typically contain thousands of genes on each chip, and the number of collected tumor samples is much smaller than that of genes, we have m ) n. The element a ql in A is the expression level of the qth gene in the lth assay (1 q m; 1 l n). The n-dimensional vector r q , i.e., the qth row of A, denotes the expression profile of the qth gene. Alternatively, the mdimensional vector c l , i.e., the lth column of A, is the snapshot of the lth assay (cell sample). Here, we suppose that the n samples belong to k object classes (k n). We arrange the n i samples of the ith class (1 i k) as a matrix A i ¼ ½c i;1 ; c i;2 ; . . . c i;n i 2 IR mÂn i with each sample being a column. Given that the training samples of the ith class are sufficient, any new (testing) sample y 2 IR m in the same class will approximately lie in the linear span of the training samples associated with class i [18] :
for some scalars i;j 2 IR; j ¼ 1; 2; . . . ; n i . For tumor classification, the membership i of the new testing sample y is unknown. We arrange the training data samples of each class in matrix A. Suppose that the samples with the same class are conjoint, i.e., A ¼ ½A 1 ; A 2 ; . . . A k , then the linear representation of y can be rewritten in terms of all the training samples as
where, ideally,
is a coefficient vector whose entries are zero except for those associated with the ith class. In other words, the nonzero entries in the estimate x 0 will be associated with the columns of A from a single object class i so that we can assign the testing sample y to that class. Now, the key problem to be shoved is how to calculate x 0 . From (3), we can see that the representation of y is naturally sparse if the number of object classes k is large. The problem can be converted into how to find a column vector x such that y ¼ Ax and kxk 0 is minimized, where kxk 0 is the l 0 -norm of x and it is equivalent to the number of nonzero elements in vector x, i.e., the so-called sparse representation. It can be expressed as the following optimization problem:
Finding the solution to the above SR problem is NP-hard due to its nature of combinational optimization [27] . Fortunately, recent development in the theory of SR and compressive sensing [13] , [14] , [15] , [16] reveals that if the solution being sought is sparse enough, the solution to the l 0 -minimization problem in (4) is equivalent to the solution to the following l 1 -minimization problem:
This problem can be solved in polynomial time by standard linear programming methods [12] . For A, whose size m ) n, (5) does not have exact solutions. To solve this problem, we consider a generalized version of (5), which allows for certain degree of noise, i.e., find a vector x such that the following objective function is minimized:
1. In [5] , the authors used the term "metagene" to represent metasample.
TABLE 1 Abbreviations
Jðx; Þ ¼ min
Using this, (5) is reduced to solving an l 1 -regularized least square problem. The positive parameter in (6) is a scalar regularization that balances the reconstruction error and sparsity. This optimization problem can also be solved by standard linear programming methods [12] . In this study, we use the truncated Newton interior-point method [17] to solve this problem.
Metasample of Gene Expression Data
Generally speaking, metasample of gene expression data is defined as a linear combination of several samples, which may capture alternative structures inherent to the data and provide biological insight. Another viewpoint of metasample is that we can approximate the gene expression pattern as linear combinations of these metasamples. Mathematically, the gene expression data set matrix A can be factorized into two matrices
where matrix W is of size m Â p, with each of the p columns defining a metasample. Matrix H is of size p Â n, with each of the n columns representing the metasample expression pattern of the corresponding sample (refer to Fig. 1 ). Many works have been published on extracting the metasamples [5] , [22] , [23] . Alter et al. [22] used SVD to transform the gene expression data from the "genes Â samples" space to diagonalized "eigengenes Â eigenarrays (i.e., metasamples)" space, where the eigengenes (or eigenarrays) are unique orthonormal superposition of the genes (or samples). They found that sorting the data according to the eigengenes and eigenarrays gives a global picture of the dynamics of gene expression, in which individual genes and arrays appear to be classified into groups of similar regulation and function, or similar cellular state and biological phenotype, respectively. After normalization and sorting, the significant eigengenes and eigenarrays can be associated with observed genome-wide effects of regulators, or with measured samples, in which these regulators are overactive or underactive, respectively.
In our previous works [9] , [25] , ICA was used to model gene expression data as shown in Fig 1. In this model, the samples are considered to be a linear mixture of statistically independent basis snapshots (i.e., metasamples). On the other hand, Brunet et al. [5] used NMF to describe the gene expression data in terms of a small number of metasamples. Then the samples are analyzed by summarizing their gene expression patterns in terms of expression patterns of the metasamples. It was shown in [5] that the metasample expression patterns provide a robust clustering of samples.
Form the above analysis, we see that the metasamples can be extracted using several methods, such as SVD, ICA, NMF, etc. Based on the method used, different names were proposed, including eigengene, eigenarray, independent basis snapshot, and metasample. We choose the name "metasample." In the following section, we use SVD and sparse NMF (SNMF) to extract the metasamples for classification because of their efficiency.
Metasample-Based Sparse Representation Classification
Since the metasamples contain the inherent structural information of training samples, in this study, we propose to use them to design the classifier instead of the original samples in training data set. We extract the metasamples from the samples in each class, respectively, i.e., we factorize each subdata set matrix A i into two matrices:
where W i is an m Â p i matrix and H i is a p i Â n i matrix. p i is the number of metasamples of the ith class. In practice, the value of p i can be determined experimentally. In this study, we use SVD and SNMF to solve (8) for W i . After computing the metasamples W i of each class, we use W to represent the metasamples from all the k classes:
Given a new test sample y, we can compute its SR by minimizing
where the positive scalar regularization parameter is determined experimentally. Ideally, the nonzero entries in the representation vector x will all be associated with the columns of W from a single class i, allowing us to assign the testing sample y to the class i. However, noise and modeling error will inevitably lead to small nonzero entries associated with multiple object classes [18] . To solve this problem and for a more robust classification, we classify y based on how well y can be reconstructed by using the coefficients from each class as in [18] .
For each class i, let i : IR n ! IR n be the characteristic function which selects the coefficients associated with the ith class. For x 2 IR n ; i ðxÞ 2 IR n is a vector whose nonzero entries are the ones from class i in x. Using only the coefficients from the ith class, one can reconstruct the given test sample y asŷ i ¼ W i ðxÞ. We then classify y based on these approximations by assigning it to the class that minimizes the residual between y andŷ:
The classification algorithm can be summarized as following:
Input: matrix of training samples A ¼ ½A 1 ; A 2 ; . . . ; A k 2 IR mÂn for k classes; testing sample y 2 IR m . Step1: Normalize the columns of A to have unit l 2 -norm.
Step2: Extract the metasamples of every class using SVD or NMF. Step3: Solve the optimization problem defined in (10) . Step4: Compute the residuals r i ðyÞ ¼ ky À W i ðxÞk 2 . Output: identity(y) = arg min i r i ðyÞ.
Since our algorithm is based on metasamples, we name it the metasample-based sparse representation classification. The optimization problem in (10) is solved using the truncated Newton interior-point method, which is done by l1_ls Matlab package available online (http:// www.stanford.edu/~boyd/l1\_ls). The Matlab codes of the proposed MSRC algorithm can be downloaded at http://www4.comp.polyu.edu.hk/~cslzhang/code/ MSRC_IEEE.rar.
MSRC can be seen as the combination of SRC [18] and metasample-based clustering [5] . In SRC, the testing sample is represented as a linear combination of the original training samples. In metasample-based clustering, each sample is represented as a linear combination of metasamples, which are extracted from the training samples. The common point of the two methods is that they are both using the coefficient vector for classification or clustering. The difference between them is that in the proposed MSRC, the testing sample is represented as a linear combination of metasamples extracted in a supervised manner from each class separately.
Evaluation of Performance
The proposed method is evaluated in comparison with some representative methods, including the SRC [18] , [19] , LASSO [40] and the widely used support vector machines (SVM) [28] . SVM has been successfully used for gene profile classification [28] . Considering the characteristics of "high dimensionality and small sample size" of gene expression data, SVM may be the best classifier for classifying the original data [29] , [30] . Statnikov et al. [29] and Pochet et al. [30] compared various methods for tumor classification and concluded that SVM is among the most efficient ones, outperforming K-nearest neighbors (KNN) and neural network. Based on this conclusion, KNN and neural network will not be used in the comparison, though they are also useful for tumor classification. In addition, it has been reported that SRC has similar performance to SVM in classification [18] .
The experiments of two-class classification are given in Section 3.1. We use classification accuracy, sensitivity, and specificity, as the performance metrics. They are obtained by stratified 10-fold cross validation. The results of SVM are obtained by the Gene Expression Model Selector (GEMS), a set of softwares with graphic user interface for gene expression data classification. GEMS is publically available at http://www.gems-system.org/ and it was also used in [29] for the comprehensive study of many classifiers on gene expression cancer diagnosis. In this study, we use oneversus-rest SVM (OVRSVM) with Polynomial kernels to do the experiment because Statinkov et al. have shown that OVRSVM may be the best one for tumor classification [29] .
Nested stratified 10-fold cross-validation method [29] is used to select the parameters of the classifiers, which is based on two loops. The inner loop is used to determine the best parameter of the classifier. The outer loop is used for estimating the performance of the classifier. Fig. 2 shows a simplified pictorial example of a nested stratified 3-fold cross validation applied to optimize the parameter C (which takes values "1" and "2") of a classifier. Note that in reality, we will optimize a set of combined parameters.
The multiclass classification experiments are given in Section 3.2. Because the LASSO-based method is designed for two-class classification problem [40] , we do not use it for multiclass tumor classification. The numbers of training samples in different classes are unbalanced, e.g., in the lung cancer data set, there are 139 adenocarcinoma samples but only six small-cell lung carcinoma samples. Thus in the experiments, we can set different numbers of metasamples according to the numbers of samples in different classes, i.e., more metasamples will be extracted if the number of training samples of that class is bigger. However, the classification results may be biased toward classes with greater numbers of metasamples. On the other hand, if the number of metasamples of each class is set the same, it must be equal to or less than the smallest n i , and thus, we will lose the information contained in larger classes. With the above considerations and according to the results of nested stratified 10-fold cross validation, we choose p i ¼ 8 if n i > 8. Otherwise, we let p i ¼ n i .
To study whether dimensionality reduction can improve the classification performance, we also applied SRC, LASSO, SVM, and MSRC to subsets of selected top-ranked genes. It should be noted that since the number of genes are very large, an optimal selection of the genes is very computationally expensive. Considering that our aim is to validate whether gene selection can benefit MSRC and the fact that cancer is caused by the mutation of many genes, we use a simple method, i.e., the ratio of genes betweencategories to within-category sums of squares (BW) method, to rank the genes, and select a comparatively large number of genes for the experiment. 2 . An example of parameter selection. Data are split into mutually exclusive sets P 1 ; P 2 , and P 3 . The performance is estimated in the outer loop by training on all splits but one, and using the remaining one for testing. The average performance over testing sets is reported. The inner loop is used to determine the optimal value of parameter C (in a cross-validated fashion) for training in the outer loop.
Two-Class Classification
Four publicly available microarray data sets are used to study the tumor classification problem: Acute leukemia data set [3] , Colon cancer data set [4] , Prostate cancer data set [37] , and Diffuse large B-cell lymphomas (DLBCL) data set [36] .
The leukemia data set is consisted of 38 bone marrow samples, which were obtained from adult acute leukemia patients at the time of diagnosis and before chemotherapy. RNA prepared from bone marrow mononuclear cells was hybridized to high-density oligonucleotide microarrays to measure the gene expression values. For the colon data set, gene expression in 40 tumor and 22 normal colon tissue samples was analyzed with an Affymetrix oligonucleotide array complementary to more than 6,500 human genes. The data set contains the expression of 2,000 genes with the highest minimal intensity across 62 tissues. For the prostate data set, the gene expression profiles were derived from prostate tumors and nontumor prostate samples from patients undergoing surgery. Oligonucleotide microarrays containing probes for approximately 12,600 genes and ESTs were used for obtaining the gene expression data. For the DLBCL data set, RNA was hybridized to high-density oligonucleotide microarrays to measure the gene expression values. An overview of the characteristics of the four data sets is given in Table 2 .
The classification results (including accuracy, sensitivity, and specificity) by using SVM, LASSO, SRC, and the proposed MSRC are listed in Tables 3, 4 , and 5. SVD and SNMF are used to extract the metasamples of gene expression data, respectively. When using the two methods to extract the metasamples, we need to determine the number of metasamples of each class, i.e., the value of p i in (8) . Since there are only 2 classes and the difference of the number of samples in each class is not big, we let p 1 ¼ p 2 ¼ p. The value of p can be determined using the nested stratified 10-fold cross validation. Another parameter in (10) can also be determined TABLE 5 The Classification Specificity by Different Methods using this method. Note that, the results of SVM and SRC in our experiments are slightly different from those reported in [19] , [29] . This is probably because the distribution file of cross validation in our experiments is different from those in [19] , [29] .
To better illustrate the experimental results, we show the accuracies of our methods MSRC-SVD and MSRC-SNMF in Figs. 3, 4 , 5, and 6 when different numbers of metasamples are used. The x-axis represents the p-dimension, i.e., the number of metasamples extracted from the original data; yaxis represents the accuracy of classification.
From Tables 3, 4 , 5 and Figs. 3, 4, 5, 6 , it can be seen that for the four data sets, MSRC-SVD achieves better classification results than SVM and SRC, especially on the colon and DLBCL data sets. The proposed MSRC-SVD is very competitive for binary tumor classification. From Figs. 3, 4 , 5, and 6, we can also find that, compared with MSRC-SNMF, MSRC-SVD could achieve higher accuracy. This may be in conflict with the intuitive sense that SNMF could model the gene expression data in a more biological way [8] . From another viewpoint, however, SVD is the optimal model for reconstruction under l 2 -norm. Certainly, more experiments could be performed to further validate this in the future.
The experimental results with gene selection are shown in Tables 6, 7, 8 and Figs. 3, 4, 5, 6 (MSRC-SVD+BW and MSRC-SNMF+BW). We can see that, except for MSRC-SNMF and LASSO, gene selection can improve the performance of all the other classification methods. For MSRC-SVD, gene selection can improve both the accuracy and the stability of the classification. For MSRC-SNMF and LASSO, no clear regularity could be found.
Multiclass Classification
We use five multiclass data sets to further investigate the performance of the proposed method.
1. The Lung cancer data set [34] , which contains four lung cancer types and normal tissues (i.e., five classes in total). This data set includes 203 samples with 12,600 genes. 2. The Leukemia data set [33] , which has three kinds of samples: acute myelogenous leukemia, acute lymphoblastic leukemia, and mixed-lineage leukemia. This data set includes 72 samples with 11,225 genes. 3. The Small round blue cell tumors of childhood (SRBCT) [35] , which is composed of four types of tumors. This data set includes 83 samples with 2,308 genes. 4. A data set composed of 11 various human tumor types (11_Tumors [32] ): ovary, bladder/ureter, breast, colorectal, gastroesophagus, kidney, liver, prostate, pancreas, adeno lung, and squamous lung. This data set includes 174 samples with 12,533 genes. 5. A data set composed of nine various human tumor types (9_Tumors [31] ): nonsmall cell lung, colon, breast, Ovarian, Leukemia, Renal, Melanoma, Prostate, and central nervous system. This data set includes 60 samples with 5,726 genes.
All the five data sets were produced by oligonucleotide microarrays. Except SRBCT, for the other four data sets RNA was hybridized to high-density oligonucleotide Affymetrix arrays, and expression values were computed using the analysis tool: Affymetrix GENECHIP [29] . The SRBCT data set was produced by using two-color cDNA platform with consecutive image analysis performed by the DeArray Software and filtering for a minimal level of expression [35] .
The experimental results are listed in Table 9 . From the five experiments we can see that, for multiclass classification the proposed MSRC does not have clear advantages over SVM and SRC. The reason is that in these data sets, the training samples of some classes are very few so that the extracted metasamples cannot represent the intrinsic information of these classes. For example, the number of samples of each class in the 9_tumors data set is listed in Table 10 . We see that the samples of each class are very few, which makes the classification result of MSRC relatively poor on this data set. Table 11 shows the experimental results with gene selection. Compared with Table 9 , we can see that except for the 9_tumors data set, little improvement is achieved by gene selection for the other three data sets. Since the accuracy on SRBCT data set is 100 percent for all the classifiers, we did not apply gene selection on this data set.
The Required Number of Samples for Metasample Training
From the aforementioned experimental results, we see that our method could efficiently classify tumor data, especially when there are enough training samples of each class. On the other hand, if the training samples are very few, our method may not be better than SVM and SRC.
To find out how many training samples are required by MSRC to perform better than SRC, we randomly select different numbers of samples from the four two-class data sets and the Leukemia data set [33] for testing. Each class in these data sets has more than 18 samples. We randomly chose 6, 10, 14, and 18 samples, respectively, from each class of the data set for classification. Each experiment was repeated 10 times. The mean classification accuracies of 10-fold cross-validation are listed in Table 12 . From this table, we can see that MSRC will not have clear advantages over SRC when the number of training samples is less than 10. If there are 10 or more than 10 training samples, MSRC will be a good choice for tumor classification. This is consistent to the results in Section 3.2.
CONCLUSION AND DISCUSSION
Cancer diagnosis is one of the most important emerging clinical applications of gene expression data. In this study, we proposed a new SR-based approach for cancer diagnosis, which expresses each testing sample as a linear combination of a set of metasamples extracted using SVD or NMF from the training samples. Classification is achieved by a discriminating function of the SR coefficients, which are obtained by l 1 -regularized least square optimization. The proposed metasample-based SR classification (MSRC) was compared with the standard SR classification (SRC) and the benchmark SVM methods on nine typical data sets. The results validated that MSRC is effective and efficient in tumor classification. Since it is not comprised of training and testing process, as other classifiers, e.g., SVM, our method (including SRC) has no overfitting problem.
The experimental results also show that, compared with SRC, MSRC is a better choice if there are 10 or more than 10 training samples. The reason may be that when there are 10 or more than 10 training samples, metasamples can capture the intrinsic structural information of the data of each class, and thus MSRC shows superior classification performance to SRC. On the other hand, if the number of training samples is less than 10, the trained metasamples may not be able to capture sufficient intrinsic structural information of each class, and the performance of MSRC is similar to or slightly worse than SRC. This is one weakness of the proposed method, i.e., the training samples for metasample training cannot be too limited. What should be noted is that, our method is based on the hypothesis that the testing sample can be well represented as a linear combination of the training samples from the same class. If the hypothesis is invalid, our method will not work. Fortunately, the success of sparse representation in face recognition [18] and gene expression data classification [19] has demonstrated that this hypothesis holds well. Certainly, more experiments on more databases need to be performed in the future to further validate the proposed method. Since gene selection can enhance the accuracy of the classification [29] , we also used gene selection to preprocess the gene expression data. As expected in theory, the experimental results showed that gene selection can enhance the performance of SVM, SRC, as well as MSRC-SVD. For MSRC-NMF, no clear rule can be found. In the future, we will investigate whether other metasample extraction methods, such as sparse PCA, KPCA, etc., will achieve better results. In addition, we will also investigate how to solve the metasample extraction and the testing sample classification as one unified optimization problem, which may improve the accuracy of classification. . For more information on this or any other computing topic, please visit our Digital Library at www.computer.org/publications/dlib.
